# Photo-Protection Trial (NB-UVB vs. Placebo) in High-risk Hospitalized COVID-19 Patients

> **NCT04818970** · NA · COMPLETED · sponsor: **Cytokind, Inc.** · enrollment: 30 (actual)

## Conditions studied

- Covid19
- Corona Virus Infection
- Autoimmune Diseases
- Coagulation Disorder, Blood

## Interventions

- **DEVICE:** Narrow Band ultraviolet B-Band Light
- **DEVICE:** non Narrow Band ultraviolet B-Band Light

## Key facts

- **NCT ID:** NCT04818970
- **Lead sponsor:** Cytokind, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2021-05-21
- **Primary completion:** 2021-10-31
- **Final completion:** 2021-12-01
- **Target enrollment:** 30 (ACTUAL)
- **Last updated:** 2022-06-15

## Collaborators

- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04818970

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04818970, "Photo-Protection Trial (NB-UVB vs. Placebo) in High-risk Hospitalized COVID-19 Patients". Retrieved via AI Analytics 2026-06-11 from https://api.ai-analytics.org/clinical/NCT04818970. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*